NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database
In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department
PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry
Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning
Professional Societies: Three Groups To File brief In Fisher’s Appeal
NCI News: Communications Office Seeks Partners for Education Programs
Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- CBER Director Vinay Prasad dared to “say no to drugs”
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









